MedPath

Transcranial Direct Current Stimulation to Treat Major Depressive Disorder

Phase 2
Completed
Conditions
Major Depressive Disorder
Registration Number
NCT01149889
Lead Sponsor
University of Sao Paulo
Brief Summary

The investigators purpose is to offer active Transcranial Direct Current Stimulation (tDCS) in patients of the investigators previous study who received either placebo or sertraline and have not responded.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Treatment ResponseWeek 1

Response is defined as MADRS \<=12 or less than 50% of baseline MADRS (Montgomery Asberg depression rating score).

Treatment responseWeek 2

Response defined as above.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Sao Paulo

🇧🇷

Sao Paulo, SP, Brazil

University of Sao Paulo
🇧🇷Sao Paulo, SP, Brazil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.